Reuters logo
BRIEF-Zhejiang Hisun Pharmaceutical sub-subsidiary passes FDA approval
September 11, 2017 / 2:32 PM / in 3 months

BRIEF-Zhejiang Hisun Pharmaceutical sub-subsidiary passes FDA approval

Sept 11(Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd :

* Says its Zhejiang-based sub-subsidiary received FDA approval for metformin sustained release tablet from U.S Food and Drug Administration

* Company will be able to sell its metformin sustained release tablet in the United States after receiving the FDA approval

Source text in Chinese: goo.gl/eyrmWr

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below